Protective action of polyelectrolytes on endothelium

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Endothelial cells are vulnerable to oxidative stress during ischemic and inflammatory conditions.
• Glycosaminoglycans (GAGs) are known for their diverse biological roles, including anticoagulation and cell signaling.
• Understanding the protective mechanisms of GAGs against free radical injury is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the protective effects of various GAGs, specifically heparin and dextran sulfate, against oxygen-free radical-induced damage in endothelial cells.
• To compare the efficacy of heparin and dextran sulfate with other GAGs like heparan sulfate and dermatan sulfate in protecting endothelial cells.
• To explore the potential therapeutic applications of these anionic polyelectrolytes in conditions involving oxidative stress.

Main Methods:

• Endothelial cells were exposed to oxygen-free radicals generated by the xanthine/xanthine oxidase (X/XO) system.
• Cell viability was assessed using standard assays.
• Lactate dehydrogenase (LDH) release into the cell media was measured to quantify cell membrane damage.
• Cells were pretreated with different GAGs, including heparin, dextran sulfate, heparan sulfate, and dermatan sulfate, for varying durations.

Main Results:

• Heparin and dextran sulfate demonstrated significant protection of endothelial cells against oxygen-free radical injury.
• Heparan sulfate and dermatan sulfate exhibited only mild protective effects on cell viability and no significant protection against LDH release.
• Pretreatment with heparin for 24 hours conferred immediate protection upon exposure to X/XO, ruling out cell growth stimulation as the mechanism.
• No significant difference in cell number was observed in cultures treated with polyelectrolytes, indicating protection was not due to increased cell proliferation.

Conclusions:

• Anionic polyelectrolytes, particularly heparin and dextran sulfate, effectively protect endothelial cells from free radical damage.
• These findings support the potential use of heparin and dextran sulfate in treating ischemic episodes and inflammatory conditions.
• The study suggests that heparin and similar compounds may play a role in preventing and treating atheroma and protecting surrounding cells from inflammatory injury.